Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Inventory (2016 - 2025)

Historic Inventory for Rockwell Medical (RMTI) over the last 17 years, with Q3 2025 value amounting to $4.0 million.

  • Rockwell Medical's Inventory fell 3267.66% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year decrease of 3267.66%. This contributed to the annual value of $5.8 million for FY2024, which is 158.41% down from last year.
  • Per Rockwell Medical's latest filing, its Inventory stood at $4.0 million for Q3 2025, which was down 3267.66% from $4.2 million recorded in Q2 2025.
  • In the past 5 years, Rockwell Medical's Inventory ranged from a high of $6.1 million in Q1 2024 and a low of $4.0 million during Q3 2025
  • Its 5-year average for Inventory is $5.2 million, with a median of $5.5 million in 2023.
  • Per our database at Business Quant, Rockwell Medical's Inventory skyrocketed by 4263.98% in 2022 and then tumbled by 3267.66% in 2025.
  • Over the past 5 years, Rockwell Medical's Inventory (Quarter) stood at $4.1 million in 2021, then soared by 42.64% to $5.8 million in 2022, then increased by 0.98% to $5.9 million in 2023, then fell by 1.58% to $5.8 million in 2024, then tumbled by 31.39% to $4.0 million in 2025.
  • Its Inventory stands at $4.0 million for Q3 2025, versus $4.2 million for Q2 2025 and $5.0 million for Q1 2025.